The 12-16-week open-label study evaluated Ruxoprubart as monotherapy in treatment-naïve PNH patients. Key findings include: CLEVELAND, March 09, 2026 (GLOBE NEWSWIRE) -- NovelMed Therapeutics Inc., a ...
Abstract: Permanent magnet synchronous machines (PMSMs) are increasingly used in diverse applications demanding high power and compact size. This trend necessitates high-speed machines with high ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果